OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance
Zhenli Guo, Milad Ashrafizadeh, Wei Zhang, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 29-53
Closed Access | Times Cited: 46
Zhenli Guo, Milad Ashrafizadeh, Wei Zhang, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 29-53
Closed Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Wnt/β-catenin-driven EMT regulation in human cancers
Wenhua Xue, Lin Yang, Chengxin Chen, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 92
Wenhua Xue, Lin Yang, Chengxin Chen, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 92
Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 85
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 85
Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy
Jingyuan Dai, Milad Ashrafizadeh, Amir R. Aref, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 103981-103981
Closed Access | Times Cited: 61
Jingyuan Dai, Milad Ashrafizadeh, Amir R. Aref, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 103981-103981
Closed Access | Times Cited: 61
Circular RNAs in EMT-driven metastasis regulation: modulation of cancer cell plasticity, tumorigenesis and therapy resistance
Milad Ashrafizadeh, Jingyuan Dai, Pedram Torabian, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 56
Milad Ashrafizadeh, Jingyuan Dai, Pedram Torabian, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 56
Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis
Beixu Li, Milad Ashrafizadeh, Taiwei Jiao
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129391-129391
Closed Access | Times Cited: 44
Beixu Li, Milad Ashrafizadeh, Taiwei Jiao
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129391-129391
Closed Access | Times Cited: 44
Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
Milad Ashrafizadeh, Wei Zhang, Yu Tian, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 229-260
Closed Access | Times Cited: 15
Milad Ashrafizadeh, Wei Zhang, Yu Tian, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 229-260
Closed Access | Times Cited: 15
The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics
B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Saad Ali Alshehri, et al.
Environmental Research (2023) Vol. 237, pp. 116894-116894
Closed Access | Times Cited: 27
B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Saad Ali Alshehri, et al.
Environmental Research (2023) Vol. 237, pp. 116894-116894
Closed Access | Times Cited: 27
Complex roles of autophagy in cancer development, immune evasion, and drug resistance
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 14
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 14
Micelle-engineered nanoplatforms for precision oncology
Wei Gao, Ashkan Bigham, Matineh Ghomi, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153438-153438
Closed Access | Times Cited: 11
Wei Gao, Ashkan Bigham, Matineh Ghomi, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153438-153438
Closed Access | Times Cited: 11
Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives
Xianbin Zhang, Yibao Fan, Rui Jing, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Xianbin Zhang, Yibao Fan, Rui Jing, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma
Md. Ataur Rahman, Meser M. Ali
Cancers (2024) Vol. 16, Iss. 17, pp. 2975-2975
Open Access | Times Cited: 9
Md. Ataur Rahman, Meser M. Ali
Cancers (2024) Vol. 16, Iss. 17, pp. 2975-2975
Open Access | Times Cited: 9
Hypoxia-associated autophagy flux dysregulation in human cancers
Jiding Fu, Jie Lin, Zili Dai, et al.
Cancer Letters (2024) Vol. 590, pp. 216823-216823
Closed Access | Times Cited: 8
Jiding Fu, Jie Lin, Zili Dai, et al.
Cancer Letters (2024) Vol. 590, pp. 216823-216823
Closed Access | Times Cited: 8
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis
Yu Tian, Meng Zhang, Lixia Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Yu Tian, Meng Zhang, Lixia Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks
Junsi Zhang, Sunwang Xu
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Junsi Zhang, Sunwang Xu
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
A review on L-methioninase in cancer therapy: Precision targeting, advancements and diverse applications for a promising future
Bhumi M. Javia, Megha S. Gadhvi, Suhas Vyas, et al.
International Journal of Biological Macromolecules (2024) Vol. 265, pp. 130997-130997
Closed Access | Times Cited: 5
Bhumi M. Javia, Megha S. Gadhvi, Suhas Vyas, et al.
International Journal of Biological Macromolecules (2024) Vol. 265, pp. 130997-130997
Closed Access | Times Cited: 5
Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 5
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 5
Manzamine A: A Promising Marine-Derived Cancer Therapeutic for Multi-targeted Interactions with E2F8, SIX1, AR, GSK-3β, and V-ATPase - A Systematic Review
Mohammad Amir Mishan, Yeun‐Mun Choo, Jeffery Winkler, et al.
European Journal of Pharmacology (2025), pp. 177295-177295
Open Access
Mohammad Amir Mishan, Yeun‐Mun Choo, Jeffery Winkler, et al.
European Journal of Pharmacology (2025), pp. 177295-177295
Open Access
DNA methylation-induced suppression of PRDM16 in colorectal cancer metastasis through the PPARγ/EMT pathway
Yu Wang, Shuai Zheng, Huabin Gao, et al.
Cellular Signalling (2025), pp. 111634-111634
Closed Access
Yu Wang, Shuai Zheng, Huabin Gao, et al.
Cellular Signalling (2025), pp. 111634-111634
Closed Access
Toyaburgine, a Synthetic N-Biphenyl-Dihydroisoquinoline Inspired by Related N,C-Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models
Suresh Awale, Juthamart Maneenet, Nguyễn Duy Phan, et al.
ACS Chemical Biology (2025)
Closed Access
Suresh Awale, Juthamart Maneenet, Nguyễn Duy Phan, et al.
ACS Chemical Biology (2025)
Closed Access
Knockdown of PPP2R2B inhibits pancreatic cancer progression via the ERK/MAPK pathway by modulating EMT and apoptosis
Fangfang Han, Zhou Chen, Cheng Ye, et al.
Research Square (Research Square) (2025)
Closed Access
Fangfang Han, Zhou Chen, Cheng Ye, et al.
Research Square (Research Square) (2025)
Closed Access
The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes
Ye Zeng, Qiang Li, Yuheng Hu, et al.
Cancer Letters (2024) Vol. 588, pp. 216769-216769
Closed Access | Times Cited: 4
Ye Zeng, Qiang Li, Yuheng Hu, et al.
Cancer Letters (2024) Vol. 588, pp. 216769-216769
Closed Access | Times Cited: 4
The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers
Somayeh Jafari, Hossein Motedayyen, Parisa Javadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Somayeh Jafari, Hossein Motedayyen, Parisa Javadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Growth Hormone Receptor Antagonist Markedly Improves Gemcitabine Response in a Mouse Xenograft Model of Human Pancreatic Cancer
Reetobrata Basu, Prateek Kulkarni, Deborah Swegan, et al.
(2024)
Open Access | Times Cited: 3
Reetobrata Basu, Prateek Kulkarni, Deborah Swegan, et al.
(2024)
Open Access | Times Cited: 3
Low expression of ELOVL6 may be involved in fat loss in white adipose tissue of cancer-associated cachexia
C. Jin, Shuangjie Wang, Xiangyu Sui, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
C. Jin, Shuangjie Wang, Xiangyu Sui, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Unveiling the Power of Flavonoids: A Dynamic Exploration of Their Impact on Cancer through Matrix Metalloproteinases Regulation
Peramaiyan Rajendran
Biomedicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 2
Peramaiyan Rajendran
Biomedicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 2
